Novartis Ag (NVSEF) Net Cash Flow (QoQ) (2009 - 2025)

Novartis Ag (NVSEF) Net Cash Flow (QoQ) (2009 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -144.65%
Sep 30, 2025 -8.59%
Jun 30, 2025 -340.00%
Mar 31, 2025 106.19%
Jun 30, 2023 -584.52%
Mar 31, 2023 98.07%
Dec 31, 2021 -248.95%
Sep 30, 2021 -195.67%
Jun 30, 2021 64.84%
Mar 31, 2021 -83.55%
Dec 31, 2017 -1,251.32%
Sep 30, 2017 -336.26%
Mar 31, 2016 93.85%
Dec 31, 2015 -1,396.90%
Dec 31, 2013 3,797,255,691.25%
Sep 30, 2013 2.83%
Jun 30, 2013 -186.21%
Mar 31, 2013 -100.00%
Mar 31, 2012 100.00%
Mar 31, 2010 -100.00%